Tislelizumab Combined With Chemotherapy in the Cross-line Treatment of First-line Resistant Advanced Gastric Cancer

NCT05751265 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

39

Enrollment

OTHER_GOV

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: Tislelizumab
DRUG: 5Fu
DRUG: Paclitaxel injection

Sponsor

Fujian Cancer Hospital